Affective disorders and biological rhythms

Annales pharmaceutiques françaises
Y Le StratP Gorwood

Abstract

Disruptions of circadian rhythms are described in affective disorders, including unipolar and bipolar disorder, but also seasonal affective disorder. Sleep-wake and hormone circadian rhythms are among the most quoted examples. Depression could be conceptualized as a desynchronization between the endogenous circadian pacemaker and the exogenous stimuli, such as sunlight and social rhythms. Accordingly, Clock genes have been studied and the literature suggests that variants in these genes confer a higher risk of relapse, more sleep disturbances associated with depression, as well as incomplete treatment response. Most of therapeutic interventions in depression have an impact on biological rhythms. Some of them exclusively act via a biological pathway, such as sleep deprivation or light therapy. Some psychosocial interventions are specifically focusing on social rhythms, particularly in bipolar disorder, in which the promotion of stabilization is emphasized. Finally, all antidepressant medications could improve biological rhythms, but some new agents are now totally focusing this novel approach for the treatment of depression.

References

Jun 1, 1991·Biological Psychiatry·H Kuhs, R Tölle
Jan 1, 1990·Journal of Psychiatric Research·A Wirz-JusticeW Pöldinger
Dec 1, 1966·The American Journal of Psychiatry·D R Hawkins, J Mendels
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·J C Gillin
Jan 1, 1996·Archives of General Psychiatry·P A MaddenN G Martin
Aug 1, 1996·Pharmacology, Biochemistry, and Behavior·L MartinetE Mocaer
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·D G BlazerM S Swartz
Jun 5, 1998·Biological Psychiatry·U HemmeterE Holsboer-Trachsler
Jul 24, 1998·Psychiatry Research·B BarbiniE Smeraldi
Jul 15, 1999·Journal of Affective Disorders·L SherN E Rosenthal
Aug 25, 1999·Biological Psychiatry·A Wirz-Justice, R H Van den Hoofdakker
Mar 10, 2000·Psychiatry Research·A J LewyR L Sack
Jul 18, 2000·American Journal of Medical Genetics·P H DesanJ Gelernter
Nov 1, 2000·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·A J LevittZ Baumal
Dec 15, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·V RaghavendraS K Kulkarni
Feb 7, 2001·Archives of General Psychiatry·J S TermanT B Cooper
Feb 22, 2001·Annual Review of Physiology·S M Reppert, D R Weaver
Jan 18, 2003·Sleep Medicine Reviews·Henner Giedke, Frank Schwärzler
Mar 26, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mariusz PappElisabeth Mocaër
Mar 26, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carolina JohanssonTimo Partonen
Jul 5, 2003·Science·Carol A DudleySteven L McKnight
Jan 28, 2004·Biological Psychiatry·Carolina JohanssonMartin Schalling
Apr 24, 2004·The Cochrane Database of Systematic Reviews·A TuunainenT Endo
Dec 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·U BailerH N Aschauer
Apr 1, 2005·The American Journal of Psychiatry·Robert N GoldenCharles B Nemeroff
Jun 14, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Alessandro SerrettiEnrico Smeraldi
Oct 27, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S H Kennedy, R Emsley
May 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Alfred J LewyVance K Bauer
Sep 5, 2006·Journal of Pineal Research·A L Morera, P Abreu
Dec 5, 2006·CNS Drugs·Michael Zupancic, Christian Guilleminault
Jan 16, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Francesco BenedettiEnrico Smeraldi
Mar 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kole RoybalColleen A McClung
Apr 26, 2007·Annals of Medicine·Timo PartonenGunter Schumann
Oct 24, 2007·Journal of Affective Disorders·Christian EvenFrédéric Rouillon
Oct 26, 2007·Depression and Anxiety·Camellia P Clark, Shahrokh Golshan

❮ Previous
Next ❯

Citations

Mar 2, 2010·Journal of Molecular Neuroscience : MN·Lauren A Segall, Shimon Amir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revue neurologique
B ClaustratF Borson-Chazot
Nihon rinsho. Japanese journal of clinical medicine
Junichi MurakamiNaoto Yamada
© 2022 Meta ULC. All rights reserved